About Karyn Frick
Karyn Frick is a chief scientific officer at Estrigenix Therapeutics.
Experience
This experience comes from Karyn Frick's profile and from SEC filings. For roles taken from filings, the years are when the filings name Karyn Frick in the role, so the role may have started earlier or lasted longer.
Estrigenix Therapeutics, Inc. Current
Chief Scientific Officer
2018 – Present · Wauwatosa, WI
Develops potential treatments for hot flashes and dementia in postmenopausal women.
MW
Medical College of Wisconsin Current
Adjunct Professor
2015 – Present
UM
University of Wisconsin-Milwaukee Current
Director & PI, UWM Promoting Equity Diversity & Academic Success Through Aging Research Program
2010 – Present
YU
Yale University
Associate Professor
2000 – 2010
Key Colleagues at Startups
The people Karyn Frick works with at each company, as listed on that company's latest Form D.
Estrigenix Therapeutics, Inc. · Form D, Jul 27, 2026
Patricia Scheller
Executive Chair
Victoria Zellmer
Chief Executive Officer
William Donaldson
PRESIDENT & Senior VICE PRESIDENT of CHEMISTRY, director
DS
Daniel Sem
Vice President of Business Development and director